US Physical Therapy (USPH) to Present at CJS Securities Conference

U.S. Physical Therapy, Inc. (NYSE: USPH) has recently announced its participation in the CJS Securities 24th Annual New Ideas Summer Conference, where Chris Reading, the Chief Executive Officer, will be presenting on July 10, 2024. As of now, the company operates 685 outpatient physical therapy clinics in 42 states and manages an additional 41 physical therapy facilities for unaffiliated third parties, including hospitals and physician groups. The company also provides industrial injury prevention services, offering onsite services for clients' employees.

In terms of financial performance, the company reported the following metrics: Revenue increased from $138.7 million in the last period to $145.2 million in the current period. Net income saw a significant jump from $9.6 million in the last period to $11.3 million in the current period. Earnings per share also experienced a notable increase, rising from $0.77 in the last period to $0.91 in the current period. Additionally, the company's operating cash flow improved from $14.8 million in the last period to $17.6 million in the current period.

Furthermore, U.S. Physical Therapy, Inc. continues to expand its footprint and enhance its offerings, reflecting its commitment to sustained growth and development within the industry. For more detailed information about the company, individuals are encouraged to visit Today the company's shares have moved 1.5% to a price of $93.0. If you want to know more, read the company's complete 8-K report here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.